proxyvotesnow.com

Home › Asset managers › Compare 2025-2026 › Vanguard vs Equitable

Vanguard vs Equitable: how alike they voted, 2025-2026

94.3% When both took a single position, they voted the same way on 94.3% of 63,224 items (59,600 the same, 3,624 different). 8,187 items where at least one of them split its funds are listed separately below. Both voted on 71,411 items in all.

Vanguard 2025-2026 · Equitable 2025-2026 · Download the item list (CSV)

By who put the item on the ballot. “Same position” = Same / (Same + Differ); split items are not in it. “Fund-level” is a second view over all common items: the chance that a fund of each manager, picked at random, voted the same way, which gives partial credit where a manager split.
Common itemsSame DifferSplit (not in %)Same position Fund-level
All ballot items 71,41159,6003,624 8,18794.3%90.8%
Board proposals 60,52549,6993,380 7,44693.6%90.0%
E&S shareholder proposals 1991032 9498.1%87.3%
Other items 10,6879,798242 64797.6%95.5%

Where they did not vote alike

Everything Voted differently Split votes

All ballot items Board proposals E&S shareholder proposals Other items

8,187 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.

CompanyMeetingProposalOn the ballot from Board recommendedVanguardEquitable
UROGEN PHARMA LTD June 22, 2026 To approve the amendment and restatement of the Articles of Association of the Company to, among other things, tie eligibility for shareholder proposals to the requirements under the Israeli Companies Law.
Corporate Governance
Other For Split
6 FOR, 1 AGAINST
Split
5 FOR, 1 AGAINST
VAT GROUP AG April 28, 2026 Transact Other Business (Voting)
Corporate Governance
Other Not determined AGAINST
6 funds
Split
3 AGAINST, 3 ABSTAIN
VERIS RESIDENTIAL, INC. May 21, 2026 To adjourn the special meeting to a later date or time if necessary or appropriate to ensure that any necessary supplement or amendment to the accompanying proxy statement is provided to Company stockholders a reasonable amount of time in advance of the special meeting or to solicit additional proxies in favor of the Merger Proposal if there are insufficient votes at the time of the special meeting to approve the Merger Proposal.
Corporate Governance
Other For FOR
23 funds
Split
4 FOR, 3 ABSTAIN
VERISIGN, INC. May 21, 2026 Stockholder Proposal Regarding an Independent Chair Policy, if Properly Presented at the Meeting
Corporate Governance
Other Against AGAINST
34 funds
Split
2 FOR, 18 AGAINST
VERISK ANALYTICS, INC. May 19, 2026 Shareholder Proposal - Shareholder Right to Act by Written Consent.
Shareholder Rights and Defenses
Other Against Split
13 FOR, 22 AGAINST
Split
10 FOR, 10 AGAINST
VERIZON COMMUNICATIONS May 21, 2026 Independent board chair
Corporate Governance
Other Against AGAINST
39 funds
Split
1 FOR, 18 AGAINST
VERTEX PHARMACEUTICALS INCORPORATED May 13, 2026 Shareholder Proposal, if properly presented at the meeting, regarding shareholder right to act by written consent.
Shareholder Rights and Defenses
Other Against Split
12 FOR, 21 AGAINST
Split
8 FOR, 10 AGAINST
VIBRA ENERGIA SA April 15, 2026 Do You Wish to Adopt Cumulative Voting for the Election of the Members of the Board of Directors, Under the Terms of Article 141 of the Brazilian Corporate Law?
Shareholder Rights and Defenses
Other None ABSTAIN
5 funds
Split
1 AGAINST, 1 ABSTAIN
VIMEO, INC. November 19, 2025 To approve the adjournment of the special meeting of Vimeo stockholders to a later date if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the merger proposal at the then-scheduled date and time of the special meeting of Vimeo stockholders.
Corporate Governance
Other For FOR
11 funds
Split
5 FOR, 1 ABSTAIN
VIPER ENERGY, INC. May 19, 2026 The approval of an amendment to the Company's certificate of incorporation to provide that stockholders holding at least 20% of the voting power, determined on a net long basis, continuously for at least one year, may call special meetings of stockholders, and other immaterial changes.
Shareholder Rights and Defenses
Other For Split
22 FOR, 1 AGAINST
FOR
7 funds
VISA INC. January 27, 2026 Shareholder proposal on shareholder right to act by written consent.
Shareholder Rights and Defenses
Other Against Split
10 FOR, 33 AGAINST
Split
2 FOR, 23 AGAINST
VISA INC. January 27, 2026 Shareholder proposal requesting the Board of Directors to adopt a policy for an independent chair.
Corporate Governance
Other Against Split
6 FOR, 36 AGAINST
Split
2 FOR, 24 AGAINST
VISA INC. January 27, 2026 To approve amendments to our Eighth Restated Certificate of Incorporation to limit officer liability as permitted by Delaware law.
Director Elections
Other For FOR
43 funds
Split
23 FOR, 3 AGAINST
VOYAGER TECHNOLOGIES, INC. May 29, 2026 To approve an adjournment of the Annual Meeting, if necessary, to solicit addition proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposal 3.
Extraordinary Transactions
Other For FOR
12 funds
Split
4 FOR, 1 AGAINST
Volvo AB April 8, 2026 Approve Publication of a Report on Company's Climate Policy Commitments and Alignment with the Paris Agreement
Environment or Climate
Other Against AGAINST
7 funds
Split
1 FOR, 7 AGAINST
WALMART INC. June 4, 2026 Approval of an Amendment to our Restated Certificate of Incorporation to limit the liability of certain officers as permitted by Delaware law
Director Elections
Other For Split
40 FOR, 1 AGAINST
Split
20 FOR, 3 AGAINST
WALMART INC. June 4, 2026 Request for Cumulative Voting for Board Elections
Shareholder Rights and Defenses
Other Against AGAINST
42 funds
Split
1 FOR, 22 AGAINST
WEATHERFORD INTERNATIONAL PLC June 11, 2026 To approve an amendment to the Weatherford-Ireland Articles so that any Weatherford-Ireland ordinary shares that are issued on or after the Voting Record Time to persons other than Weatherford-US or its nominee(s) will either be subject to the terms of the Scheme of Arrangement or will be immediately and automatically acquired by Weatherford-US and/or its nominee(s) for the Scheme Consideration (as defined in the Scheme of Arrangement).
Corporate Governance
Other For Split
31 FOR, 1 AGAINST
Split
2 FOR, 4 AGAINST
WEATHERFORD INTERNATIONAL PLC June 11, 2026 To approve any motion to adjourn the AGM, or any adjournments thereof, to another time and place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the AGM to approve the resolutions proposed at the AGM.
Corporate Governance
Other For Split
31 FOR, 1 AGAINST
Split
2 FOR, 4 AGAINST
WEATHERFORD INTERNATIONAL PLC June 11, 2026 To approve the Scheme of Arrangement by, and on behalf of, Weatherford International plc (''Weatherford-Ireland'') and to authorize the directors of Weatherford-Ireland to take all such actions as they consider necessary or appropriate for carrying the Scheme of Arrangement into effect.
Extraordinary Transactions
Other For Split
8 FOR, 1 AGAINST
FOR
1 fund
WEC ENERGY GROUP, INC. May 7, 2026 Stockholder proposal to govern by majority vote
Shareholder Rights and Defenses
Other Against Split
10 FOR, 22 AGAINST
Split
10 FOR, 8 AGAINST
WELLS FARGO & COMPANY April 28, 2026 Shareholder Proposal - Govern by Majority Vote.
Shareholder Rights and Defenses
Other Against Split
9 FOR, 37 AGAINST
Split
12 FOR, 6 AGAINST
WELLS FARGO & COMPANY April 28, 2026 Shareholder Proposal - Request for Board of Directors to Adopt Policy for an Independent Chair.
Corporate Governance
Other Against Split
6 FOR, 42 AGAINST
AGAINST
20 funds
WEST PHARMACEUTICAL SERVICES, INC. May 4, 2026 Shareholder proposal regarding an independent Board Chair policy.
Corporate Governance
Other Against Split
1 FOR, 33 AGAINST
Split
8 FOR, 10 AGAINST
WIDEOPENWEST, INC. December 3, 2025 To adjourn the special meeting of the stockholders of the Company (the "Special Meeting"), from time to time, to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting.
Corporate Governance
Other For FOR
8 funds
Split
5 FOR, 1 ABSTAIN
WK KELLOGG CO September 19, 2025 The Adjournment Proposal - To approve one or more adjournments of the special meeting, if necessary, to solicit additional proxies if a quorum is not present or there are not sufficient votes cast at the special meeting to approve the Merger Proposal.
Corporate Governance
Other For FOR
23 funds
Split
6 FOR, 2 ABSTAIN
WOODWARD, INC. January 28, 2026 Approve an amendment to the Certificate of Incorporation to eliminate cumulative voting rights in the election of directors.
Shareholder Rights and Defenses
Other For FOR
20 funds
Split
8 FOR, 1 AGAINST
WOOLWORTHS GROUP LTD October 30, 2025 Approve Farmed Seafood Reporting
Environment or Climate
Other Against AGAINST
7 funds
Split
5 FOR, 4 AGAINST
WORKDAY, INC. June 16, 2026 To consider and vote upon a stockholder proposal regarding disclosure of voting results based on share class.
Shareholder Rights and Defenses
Other Against Split
12 FOR, 24 AGAINST
Split
10 FOR, 9 AGAINST
WYNDHAM HOTELS & RESORTS, INC. May 14, 2026 To vote on a stockholder proposal, if properly presented at the meeting, regarding stockholder ability to act by written consent.
Shareholder Rights and Defenses
Other Against Split
26 FOR, 1 AGAINST
Split
11 FOR, 2 AGAINST
Waters Corporation January 27, 2026 To approve the adjournment of the Special Meeting, if necessary, (a) to solicit additional proxies in the event there are not sufficient votes at the time of the Special Meeting to approve the Share Issuance Proposal, (b) if there are insufficient shares of Waters Common Stock represented (either in person via the Internet or by proxy) to constitute a quorum necessary to conduct business at the Special Meeting, or (c) to allow reasonable time for the filing or mailing of any supplemental or amended disclosures that the Company has determined, based on the advice of outside legal counsel, are reasonably likely to be required under applicable law and for such supplemental or amended disclosures to be disseminated and reviewed by the Company's stockholders.
Corporate Governance
Other For FOR
29 funds
Split
22 FOR, 1 AGAINST
XCF GLOBAL, INC. March 6, 2026 To authorize an adjournment of the meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes in favor of Proposal 1
Corporate Governance
Other For Split
4 FOR, 1 AGAINST
FOR
4 funds
YA-MAN Ltd. July 25, 2025 Amend Articles to Adopt Board Structure with Audit Committee - Amend Provisions on Number of Directors - Add/Amend Provisions on Corporate Officers - Indemnify Directors - Change Fiscal Year End - Authorize Board to Determine Income Allocation
Corporate Governance
Other For FOR
6 funds
Split
1 FOR, 1 AGAINST
YUM! BRANDS, INC. May 14, 2026 Shareholder Proposal to Reduce the Percentage of Shares Required to Call a Special Meeting.
Shareholder Rights and Defenses
Other Against Split
12 FOR, 23 AGAINST
Split
12 FOR, 9 AGAINST
Yakult Honsha Co., Ltd. June 24, 2026 Approve Restricted Stock Plan
Compensation
Other Against AGAINST
7 funds
Split
1 FOR, 1 AGAINST
Yellow Hat Ltd. June 24, 2026 Approve Restricted Stock Plan
Compensation
Other Against AGAINST
7 funds
Split
1 FOR, 1 AGAINST
ZIMVIE INC. October 10, 2025 A proposal to approve any adjournment of the special meeting for the purpose of soliciting additional proxies if there are insufficient votes at the special meeting to approve Proposal 1.
Corporate Governance
Other For FOR
9 funds
Split
6 FOR, 2 ABSTAIN
ZOETIS INC. May 20, 2026 Shareholder proposal to permit shareholder action by written consent.
Shareholder Rights and Defenses
Other Against Split
14 FOR, 24 AGAINST
Split
9 FOR, 12 AGAINST
ZURA BIO LIMITED June 17, 2026 Adjournment of the Annual General Meeting: To approve, by ordinary resolution, the adjournment of the Annual General Meeting by the chairman thereof to a later date, if necessary, for the purpose of soliciting additional proxies in favor of the foregoing proposals, in the event the Company does not receive the requisite shareholder votes to approve the foregoing proposals.
Corporate Governance
Other For Split
1 FOR, 1 AGAINST
AGAINST
1 fund
ZURICH INSURANCE GROUP AG April 8, 2026 Transact Other Business (Voting)
Corporate Governance
Other Not determined AGAINST
7 funds
Split
4 AGAINST, 3 ABSTAIN
bioMerieux SA May 28, 2026 Appoint Jean-Luc Belingard as Censor
Corporate Governance
Other For AGAINST
6 funds
Split
4 FOR, 4 AGAINST
1-800-FLOWERS.COM, INC. December 10, 2025 To approve an amendment to the 2003 Long Term Incentive and Share Award Plan to increase the authorized shares.
Compensation
Board For FOR
6 funds
Split
3 FOR, 2 AGAINST
1-800-FLOWERS.COM, Inc. December 10, 2025 Election of Directors: Adam Hanft
Director Elections
Board For FOR
6 funds
Split
3 FOR, 1 WITHHOLD
1-800-FLOWERS.COM, Inc. December 10, 2025 Election of Directors: Celia R. Brown
Director Elections
Board For FOR
6 funds
Split
3 FOR, 1 WITHHOLD
1-800-FLOWERS.COM, Inc. December 10, 2025 Election of Directors: Christina Shim
Director Elections
Board For FOR
6 funds
Split
3 FOR, 1 WITHHOLD
1-800-FLOWERS.COM, Inc. December 10, 2025 Election of Directors: Christopher G. McCann
Director Elections
Board For FOR
6 funds
Split
3 FOR, 1 WITHHOLD
1-800-FLOWERS.COM, Inc. December 10, 2025 Election of Directors: Dina Colombo
Director Elections
Board For FOR
6 funds
Split
3 FOR, 1 WITHHOLD
1-800-FLOWERS.COM, Inc. December 10, 2025 Election of Directors: Eugene F. DeMark
Director Elections
Board For FOR
6 funds
Split
3 FOR, 1 WITHHOLD
1-800-FLOWERS.COM, Inc. December 10, 2025 Election of Directors: James F. McCann
Director Elections
Board For FOR
6 funds
Split
3 FOR, 1 WITHHOLD
10X GENOMICS, INC. June 4, 2026 Election of the Class I directors listed in the accompanying proxy statement, to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal Serge Saxonov
Director Elections
Board For FOR
21 funds
Split
4 FOR, 3 AGAINST
1ST SOURCE CORPORATION April 23, 2026 Election of Directors for terms expiring April 2029: Christopher J. Murphy III
Director Elections
Board For FOR
15 funds
Split
3 FOR, 1 AGAINST
1ST SOURCE CORPORATION April 23, 2026 Election of Directors for terms expiring April 2029: Timothy K. Ozark
Director Elections
Board For FOR
15 funds
Split
3 FOR, 1 AGAINST
1ST SOURCE CORPORATION April 23, 2026 Election of Directors for terms expiring April 2029: Todd F. Schurz
Director Elections
Board For FOR
15 funds
Split
3 FOR, 1 AGAINST
3D SYSTEMS CORPORATION May 14, 2026 The approval of an amendment to our Certificate of Incorporation, as amended, to increase the total number of authorized shares of our common stock, par value $0.001 per share, from 220,000,000 shares to 440,000,000 shares.
Capital Structure
Board For Split
8 FOR, 2 AGAINST
FOR
6 funds
3D SYSTEMS CORPORATION May 14, 2026 The approval of the amendment and restatement of the 2015 Incentive Plan to increase the number of shares reserved for issuance thereunder by 4,000,000 shares and to extend the term until 2036.
Compensation
Board For Split
7 FOR, 3 AGAINST
FOR
6 funds
3D SYSTEMS CORPORATION May 14, 2026 The election of the nine directors named in the accompanying Proxy Statement: Charles G. McClure, Jr.
Director Elections
Board For FOR
8 funds
Split
5 FOR, 1 AGAINST
3D SYSTEMS CORPORATION May 14, 2026 The election of the nine directors named in the accompanying Proxy Statement: Claudia N. Drayton
Director Elections
Board For FOR
8 funds
Split
5 FOR, 1 AGAINST
3D SYSTEMS CORPORATION May 14, 2026 The election of the nine directors named in the accompanying Proxy Statement: Jeffrey A. Graves
Director Elections
Board For FOR
8 funds
Split
5 FOR, 1 AGAINST
3D SYSTEMS CORPORATION May 14, 2026 The election of the nine directors named in the accompanying Proxy Statement: Jim D. Kever
Director Elections
Board For FOR
8 funds
Split
5 FOR, 1 AGAINST
3D SYSTEMS CORPORATION May 14, 2026 The election of the nine directors named in the accompanying Proxy Statement: John J. Tracy
Director Elections
Board For FOR
8 funds
Split
5 FOR, 1 AGAINST
3D SYSTEMS CORPORATION May 14, 2026 The election of the nine directors named in the accompanying Proxy Statement: Kevin S. Moore
Director Elections
Board For FOR
8 funds
Split
5 FOR, 1 AGAINST
3D SYSTEMS CORPORATION May 14, 2026 The election of the nine directors named in the accompanying Proxy Statement: Malissia R. Clinton
Director Elections
Board For FOR
8 funds
Split
5 FOR, 1 AGAINST
3D SYSTEMS CORPORATION May 14, 2026 The election of the nine directors named in the accompanying Proxy Statement: Thomas W. Erickson
Director Elections
Board For FOR
8 funds
Split
5 FOR, 1 AGAINST
3D SYSTEMS CORPORATION May 14, 2026 The election of the nine directors named in the accompanying Proxy Statement: Vasant Padmanabhan
Director Elections
Board For FOR
8 funds
Split
5 FOR, 1 AGAINST
4D MOLECULAR THERAPEUTICS, INC. June 17, 2026 Election of three Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected. Nancy Miller-Rich
Director Elections
Board For FOR
9 funds
Split
4 FOR, 1 WITHHOLD
8x8, Inc. July 25, 2025 To approve an amendment to the 8x8, Inc.'s 2022 Equity Incentive Plan to increase the number of shares of common stock available for issuance thereunder by 8,500,000 shares.
Compensation
Board For Split
11 FOR, 1 AGAINST
Split
4 FOR, 3 AGAINST
908 DEVICES INC June 11, 2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.
Say-on-Pay
Board For Split
10 FOR, 1 AGAINST
Split
6 FOR, 1 AGAINST
908 DEVICES INC June 11, 2026 To elect three Class III directors to hold office until the 2029 annual meeting of stockholders. Keith L. Crandell
Director Elections
Board For FOR
7 funds
Split
6 FOR, 1 WITHHOLD
A. O. Smith Corporation April 13, 2026 Election of directors: Christopher L. Mapes
Director Elections
Board For FOR
21 funds
Split
9 FOR, 8 WITHHOLD
A. O. Smith Corporation April 13, 2026 Election of directors: Dr. Ilham Kadri
Director Elections
Board For FOR
21 funds
Split
7 FOR, 10 WITHHOLD
A. O. Smith Corporation April 13, 2026 Election of directors: Lois M. Martin
Director Elections
Board For FOR
21 funds
Split
10 FOR, 7 WITHHOLD
A. O. Smith Corporation April 13, 2026 Proposal to approve, by nonbinding advisory vote, the compensation of our named executive officers:
Say-on-Pay
Board For FOR
26 funds
Split
16 FOR, 2 AGAINST
A.P. MOELLER - MAERSK A/S March 25, 2026 Reelect Allan Thygesen as Director
Director Elections
Board For FOR
6 funds
Split
4 FOR, 3 ABSTAIN
A.P. MOELLER - MAERSK A/S March 25, 2026 Reelect Julija Voitiekute as Director
Director Elections
Board For FOR
6 funds
Split
4 FOR, 3 ABSTAIN
A.P. MOELLER - MAERSK A/S March 25, 2026 Reelect Marika Fredriksson as Director
Director Elections
Board For FOR
6 funds
Split
4 FOR, 3 ABSTAIN
A.P. MOELLER - MAERSK A/S March 25, 2026 Reelect Robert Maersk Uggla as Director
Director Elections
Board For FOR
6 funds
Split
4 FOR, 3 ABSTAIN
A.P. MOELLER - MAERSK A/S March 25, 2026 Reelect Thomas Lindegaard Madsen as Director
Director Elections
Board For FOR
6 funds
Split
4 FOR, 3 ABSTAIN
A10 NETWORKS, INC. April 22, 2026 To approve, on an advisory and non-binding basis, the compensation of our named executive officers.
Say-on-Pay
Board For Split
24 FOR, 1 AGAINST
Split
5 FOR, 2 AGAINST
AAON, INC. May 12, 2026 Election of Directors for a term ending in 2029: Caron A. Lawhorn
Director Elections
Board For FOR
17 funds
Split
2 FOR, 4 AGAINST
AAON, INC. May 12, 2026 Election of Directors for a term ending in 2029: David R. Stewart
Director Elections
Board For FOR
17 funds
Split
2 FOR, 4 AGAINST
AAON, INC. May 12, 2026 Election of Directors for a term ending in 2029: Stephen O. LeClair
Director Elections
Board For Split
15 FOR, 1 AGAINST
Split
2 FOR, 4 AGAINST
AAR CORP. September 16, 2025 Election of four directors named in the proxy statement: Ellen M. Lord
Director Elections
Board For FOR
14 funds
Split
5 FOR, 3 AGAINST
AAR CORP. September 16, 2025 Election of four directors named in the proxy statement: Jeffrey N. Edwards
Director Elections
Board For FOR
13 funds
Split
5 FOR, 3 AGAINST
AAR CORP. September 16, 2025 Election of four directors named in the proxy statement: Marc J. Walfish
Director Elections
Board For FOR
13 funds
Split
5 FOR, 3 AGAINST
AB SAGAX May 8, 2026 APPROVE ISSUANCE OF UP TO 10 PERCENT OF SHARE CAPITAL WITHOUT PREEMPTIVE RIGHTS
Capital Structure
Board For FOR
8 funds
Split
4 FOR, 3 AGAINST
AB SAGAX May 8, 2026 REELECT DAVID MINDUS AS DIRECTOR
Director Elections
Board For FOR
8 funds
Split
3 FOR, 4 AGAINST
AB SAGAX May 8, 2026 REELECT FILIP ENGELBERT AS DIRECTOR
Director Elections
Board For FOR
8 funds
Split
3 FOR, 4 AGAINST
ABACUS GLOBAL MANAGEMENT, INC. June 3, 2026 Approval, by an advisory vote, of the compensation of the Company's Named Executive Officers.
Say-on-Pay
Board For Split
1 FOR, 12 AGAINST
AGAINST
6 funds
ABBOTT LABORATORIES April 24, 2026 Election of 12 Directors: N. McKinstry
Director Elections
Board For FOR
28 funds
Split
17 FOR, 1 AGAINST
ABBOTT LABORATORIES April 24, 2026 Election of 12 Directors: R. B. Ford
Director Elections
Board For FOR
28 funds
Split
17 FOR, 1 AGAINST
ABBOTT LABORATORIES April 24, 2026 Say on Pay - An Advisory Vote on the Approval of Executive Compensation
Say-on-Pay
Board For FOR
52 funds
Split
19 FOR, 1 AGAINST
ABC-MART, INC. May 26, 2026 Elect Director Hattori, Kiichiro
Director Elections
Board For AGAINST
6 funds
Split
1 FOR, 1 AGAINST
ABEONA THERAPEUTICS INC. June 12, 2026 To approve an increase in the number of shares reserved for issuance under the Second Amended and Restated Abeona Therapeutics Inc. 2023 Equity Incentive Plan from 8,400,000 to 11,500,000.
Compensation
Board For FOR
7 funds
Split
6 FOR, 1 AGAINST
ABEONA THERAPEUTICS INC. June 12, 2026 To approve, on an advisory basis, the compensation of the Company's named executive officers.
Say-on-Pay
Board For Split
9 FOR, 1 AGAINST
Split
6 FOR, 1 AGAINST
ABERCROMBIE & FITCH CO. June 3, 2026 Advisory vote to approve the compensation of the Company's named executive officers for the fiscal year ended January 31, 2026.
Say-on-Pay
Board For Split
27 FOR, 6 AGAINST
FOR
10 funds
ABM INDUSTRIES INCORPORATED March 25, 2026 Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending October 31, 2026.
Audit-related
Board For Split
17 FOR, 4 AGAINST
FOR
7 funds
ABSCI CORPORATION June 4, 2026 The election of the Class II directors nominated by the Board of Directors and named in the Proxy Statement to hold office for a three-year term expiring at our 2029 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified. Prof Sir Menelas Pangalos, Ph.D.
Director Elections
Board For FOR
7 funds
Split
5 FOR, 1 WITHHOLD
ACADIA PHARMACEUTICALS INC. May 29, 2026 To approve an amendment to the Company's 2024 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 5,209,670 shares.
Compensation
Board For Split
28 FOR, 4 AGAINST
FOR
7 funds
ACADIAN ASSET MANAGEMENT INC. June 11, 2026 Approval of 2026 Equity Incentive Plan.
Compensation
Board For Split
18 FOR, 4 AGAINST
FOR
7 funds
ACCENDRA HEALTH, INC. May 14, 2026 Non-Binding advisory vote to approve the compensation of the Company's named executive officers.
Say-on-Pay
Board For Split
16 FOR, 2 AGAINST
FOR
5 funds

← Previous Page 8 of 82 Next →

← All 20 managers, 2025-2026

How items are matched and positions counted: see the comparison table and the methodology. Built October 25, 2026 from SEC Form N-PX filings.